illustrated that SIT treatment led to G1 arrest in human breast cancer MDA-MB-231 cells corresponding to reduced levels of cyclinD1 and cyclin-dependent kinase (CDK) and increased levels of p21/Cip1 and p27/Kip1 proteins involved in inhibiting the kinase activity of CDK (27). The gene discussed is CCND1; the disease is breast cancer.